We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRT icon
601
Vertiv
VRT
$104B
$422K 0.05%
4,245
-8,431
-67% -$699K
TMHC icon
602
Taylor Morrison
TMHC
$419K 0.05%
+5,969
New +$382K
ATS icon
603
ATS Corp
ATS
$2.62B
$419K 0.05%
+14,425
New +$417K
EQH icon
604
Equitable Holdings
EQH
$13.5B
$419K 0.05%
+9,962
New +$409K
MGPI icon
605
MGP Ingredients
MGPI
$400M
$417K 0.05%
+5,011
New +$414K
TFII icon
606
TFI International
TFII
$12.1B
$415K 0.05%
+3,031
New +$447K
CALX icon
607
Calix
CALX
$2.34B
$412K 0.05%
10,627
-8,692
-45% -$319K
NVMI
608
Nova
NVMI
$12.8B
$411K 0.05%
1,975
+435
+28% +$92.8K
JNJ icon
609
Johnson & Johnson
JNJ
$643B
$411K 0.05%
2,538
-5,914
-70% -$942K
ACIW icon
610
ACI Worldwide
ACIW
$6.1B
$410K 0.05%
+8,062
New +$369K
XNCR icon
611
Xencor
XNCR
$1.48B
$410K 0.05%
+20,383
New +$383K
AVNW icon
612
Aviat Networks
AVNW
$264M
$409K 0.05%
18,930
+10,508
+125% +$280K
AGI icon
613
Alamos Gold
AGI
$12.1B
$409K 0.05%
+20,533
New +$377K
TSEM icon
614
Tower Semiconductor
TSEM
$22.9B
$409K 0.05%
+9,248
New +$379K
MUR icon
615
Murphy Oil
MUR
$5.25B
$409K 0.05%
12,121
+4,454
+58% +$168K
TER icon
616
Teradyne
TER
$50.2B
$408K 0.05%
+3,049
New +$411K
TDW icon
617
Tidewater
TDW
$3.71B
$408K 0.05%
5,679
-2,131
-27% -$186K
GPRK icon
618
GeoPark
GPRK
$601M
$407K 0.05%
51,714
+3,901
+8% +$35.7K
AMD icon
619
Advanced Micro Devices
AMD
$741B
$405K 0.05%
+2,466
New +$375K
MEOH icon
620
Methanex
MEOH
$4.12B
$402K 0.05%
9,726
+4,929
+103% +$220K
OC icon
621
Owens Corning
OC
$11.5B
$400K 0.05%
+2,268
New +$382K
IDT icon
622
IDT Corp
IDT
$1.69B
$400K 0.05%
10,470
-4,279
-29% -$159K
LNN icon
623
Lindsay Corp
LNN
$1.17B
$400K 0.05%
+3,206
New +$385K
AVB icon
624
AvalonBay Communities
AVB
$27.2B
$399K 0.05%
+1,773
New +$383K
IT icon
625
Gartner
IT
$10.4B
$399K 0.05%
787
-24
-3% -$11.5K
23 24
25
26 27

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.